January 9, 2017 / 9:11 PM / 10 months ago

BRIEF-Halozyme sees FY 2017 revenue $115 mln to $130 mln

Jan 9 (Reuters) - Halozyme Therapeutics Inc :

* Halozyme provides program updates, 2017 financial guidance at 35th annual JP Morgan healthcare conference

* Sees FY 2017 revenue $115 million to $130 million

* Sees FY 2016 revenue $20 million

* Company expects to report $20 million in 2016 revenue for reimbursed partner research and development expenses that will not recur in 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below